IBD patients with concomitant IMIDs seem to have a more aggressive disease phenotype [9,12,13], with higher rates of surgery and treatment with anti-TNF agents, and, in UC, a more frequent pancolonic extent of the disease [12,13]. Here, TNF is linked to inflammatory bowel disease.